These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22156807)

  • 1. Upstream palliative care for the patient with a left ventricular assist device as destination therapy.
    Byram EK
    Dimens Crit Care Nurs; 2012; 31(1):18-24. PubMed ID: 22156807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of left ventricular assist devices in the treatment of class IV heart failure patients: what the non-heart failure specialist needs to know.
    Ahmed M; Aranda JM; Schofield RS; Bell JM; Reid JA; Klodell CT
    Cardiol Rev; 2013; 21(1):37-41. PubMed ID: 22643346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of Bereaved Caregivers and Clinicians About End-of-Life Care for Patients With Destination Therapy Left Ventricular Assist Devices.
    Chuzi S; Ogunseitan A; Cameron KA; Grady K; Schulze L; Wilcox JE
    J Am Heart Assoc; 2021 Aug; 10(15):e020949. PubMed ID: 34308687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: left ventricular assist devices and total artificial hearts.
    Rady MY; Verheijde JL
    J Intensive Care Med; 2014; 29(1):3-12. PubMed ID: 22398630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-care and communication issues at the end of life of recipients of a left-ventricular assist device as destination therapy.
    Ben Gal T; Jaarsma T
    Curr Opin Support Palliat Care; 2013 Mar; 7(1):29-35. PubMed ID: 23314013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications in patients with ventricular assist devices.
    Barnes K
    Dimens Crit Care Nurs; 2008; 27(6):233-41; quiz 242-3. PubMed ID: 18953188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation of the HeartWare left ventricular assist device.
    Slaughter MS
    Semin Thorac Cardiovasc Surg; 2011; 23(3):245-7. PubMed ID: 22172363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HeartMate II left ventricular assist device: a new device for advanced heart failure.
    Delgado R; Bergheim M
    Expert Rev Med Devices; 2005 Sep; 2(5):529-32. PubMed ID: 16293063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical challenges with the left ventricular assist device as a destination therapy.
    Rizzieri AG; Verheijde JL; Rady MY; McGregor JL
    Philos Ethics Humanit Med; 2008 Aug; 3():20. PubMed ID: 18694496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Destination therapy with left ventricular assist devices: patient selection and outcomes.
    Slaughter MS; Meyer AL; Birks EJ
    Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The price of progress: destination left ventricular assist device therapy for terminal heart failure.
    Selzman CH; Oberlander J
    N C Med J; 2006; 67(2):116-7. PubMed ID: 16752714
    [No Abstract]   [Full Text] [Related]  

  • 15. The next treatment option: using ventricular assist devices for heart failure.
    Stahovich M; Chillcott S; Dembitsky WP
    Crit Care Nurs Q; 2007; 30(4):337-46. PubMed ID: 17873570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular failure after left ventricular assist device implantation with concomitant pulmonary embolectomy needing right ventricular assist device support in a patient with terminal heart failure and asymptomatic pulmonary thrombus.
    Stepanenko A; Potapov EV; Krabatsch T; Hetzer R
    Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):154-5. PubMed ID: 19833639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient selection for left ventricular assist devices.
    Khazanie P; Rogers JG
    Congest Heart Fail; 2011; 17(5):227-34. PubMed ID: 21906247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular assist devices as a 'bridge to recovery': where do we stand?
    Ibrahim M; Hendry P
    Can J Cardiol; 2004 May; 20(7):722-4. PubMed ID: 15197426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular assist devices in the adult.
    Richards NM; Stahl MA
    Crit Care Nurs Q; 2007; 30(2):104-18; quiz 119-20. PubMed ID: 17356352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy.
    Swetz KM; Freeman MR; AbouEzzeddine OF; Carter KA; Boilson BA; Ottenberg AL; Park SJ; Mueller PS
    Mayo Clin Proc; 2011 Jun; 86(6):493-500. PubMed ID: 21628614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.